From the fringe of the fringe to the brink of a revolution in medicine – we get the cell and gene therapy story from the society that was there at the very beginning: ISCT – in this month’s cover feature. Best Practice looks at the importance of the patient voice in drug development, and why single-use systems have come to be so well regarded. In NextGen, we find out about the problem with patents when it comes to artificial intelligence. We also sit down with Kelly Chibale to discover his passion for Africa’s pharma industry.
October 5, 2020
SCHOTT introduces an online shop with low minimum order quantities to help smaller companies overcome the challenges associated with conventional purchase order procedures for primary packaging.
0 min read
September 30, 2020
Nominations are now open for The Medicine Maker 2021 Power List.
1 min read
September 23, 2020
We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis
1 min read
September 17, 2020
From the fringe of the fringe to the brink of a revolution in medicine; this is the cell and gene therapy story as told by the society that was there at the very beginning – the ISCT
1 min read
September 16, 2020
The first steps towards an autologous cell therapy for obesity
1 min read
September 16, 2020
The UK’s medicines regulator releases new guidance for Brexit
1 min read
September 9, 2020
To reap the rewards of artificial intelligence and machine learning, biotech companies must overcome the legal, regulatory, and commercial hurdles
1 min read
September 7, 2020
Do economic incentives damage the integrity of clinical trials?
1 min read
September 2, 2020
Drug development needs to move more rapidly, but not at the expense of safety
1 min read
August 31, 2020
A growing number of analytical tools can – and should – be used to assess drug quality and purity. But one technique that is seeing increasing popularity, in part due to its precision and reproducibility, is capillary electrophoresis.
0 min read
August 20, 2020
Single-use systems have come a long way. Timothy Korwan, Director, New Product Development – Single-use, and Sean DeFusco, General Manager, both at Avantor, to discuss biopharma’s experience with the technology so far – and consider why it has become a popular choice for producing new drugs.
0 min read
August 15, 2020
No patient has contracted a viral infection from a recombinant product – but, with fewer options downstream, gene therapy manufacturers will need to focus on upstream filtration to achieve the same success
0 min read
August 4, 2020
Pharmaceutical products are made for patients, so it is essential that drug development incorporates the patient view
0 min read
July 16, 2020
Sitting Down With… Kelly Chibale, Neville Isdell Chair in African-centric Drug Discovery & Development, South Africa Research Chair in Drug Discovery, and Director, H3D, University of Cape Town, South Africa.
1 min read
June 23, 2020
Your roundup of the key scientific studies and industry announcements emerging from the pandemic
0 min read
